Subscribe

What are you looking for?

Main Menu

明報新聞網

英矽智能提名外周限制性 VAV1 分子膠降解劑

Future Wealths
Future Wealths
13 10 月, 2026
One Min Read
1 Views
0 Comments
英矽智能(3696)公布，提名ISM9546為臨床前候選化合物(PCC)。其為一款創新、口服、外周限制性VAV1分子膠降解劑，潛在用於多種自身免疫性疾病治療，包括炎症性腸病(IBD)與類風濕性關節炎(RA)等。

原文: https://finance.mingpao.com/fin/instantf/20261013/1791852597423/%E8%8B%B1%E7%9F%BD%E6%99%BA%E8%83%BD%E6%8F%90%E5%90%8D%E5%A4%96%E5%91%A8%E9%99%90%E5%88%B6%E6%80%A7-vav1-%E5%88%86%E5%AD%90%E8%86%A0%E9%99%8D%E8%A7%A3%E5%8A%91%22%20target=%22blank

Last Update: 13 10 月, 2026

Please share this article if you like it!

Link Copied!
Future Wealths
Written By

Future Wealths

Other Articles

Related Posts

Our site uses cookies. By using this site, you agree to the Privacy Policy and Terms of Use.

Accept